This technology has vast potential to help patients but remains underutilized and underappreciated. The tools are there. What’s lacking are harmonized controls, regulatory guidelines and database ...

Antibodies serve as foundational tools across a broad range of research fields from immunology to oncology and infectious ...

The study showcases an innovative and effective approach for large-scale genomic research of individual cells and viral ...

Gilead Sciences, Inc. (Nasdaq: GILD) and Kite, a Gilead Company, will present 21 abstracts, including 5 oral presentations, ...

INDICATION AUCATZYL ® is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory B-cell precursor acute ...

Invited presentation followed by panel discussion on the next wave of innovation in immunotherapy of cancer: Paul Peter Tak, M.D., Ph.D., ...

SAN ANTONIO, November 05, 2025--bioAffinity Technologies announced the volume of CyPath® Lung tests processed in October ...

CEO Wenbin Jiang highlighted that "total revenue reached $52.3 million, representing a year-over-year increase of 2% compared to the same period in 2024." Jiang emphasized strong double-digit gains in ...

The Labaid Group is developing AI-based healthtech solutions and plans to establish 30 satellite cancer centres across Bangladesh to usher in a more precise healthcare. In an interview with The ...

Given that heme is central to the mechanism of action of artemisinins and some quinolines, we hypothesized that these antimalarials would exhibit strong drug-drug interactions. Previous studies using ...